3 completed, 3 unknown, 1 not yet recruiting, 1 recruiting. 3 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 1, Recruiting 1, Unknown 1 |
| Phase 3 | 1 | Completed 1 |
Follow Cardioversion: new trials by email Literature Review of Cardioversion trials Research Report on Cardioversion
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cardiovascular Performance and Exercise Response in Patients With Persistent or Permanent Atrial Fibrillation and Heart Failure Pre and Post Cardioversion or Pace and Ablate Atrial Fibrillation (AF), Heart Failure - NYHA II - IV | Not yet recruiting | Habib Khan | 40 | 2025-10-01 | 2025-10-03 | |
| MAX - SHOCK Clinical Trial biphasic defibrillator with maximum energy of 200J (® Zoll), biphasic defibrillator with maximum energy of 360J (® Physio-Control) - Cardioversion, Atrial Fibrillation | Not applicable | Recruiting | Ottawa Heart Institute Research Corporation | 376 | 2025-03-31 | 2026-02-03 |
| Heart Watch Study: a Pragmatic Randomized Controlled Trial Apple Watch, Withings Move - Cardioversion, Atrial Fibrillation | Not applicable | Completed | Yale University | 105 | 2021-08-18 | 2025-04-18 |
| Myocardial Injury Following Elective Direct Current Cardioversion for Atrial Arrhythmias Blood sample collection - Cardioversion | Completed | Mayo Clinic | 104 | 2019-07-22 | 2022-01-05 | |
| Left Atrial Thrombus on Transesophageal Echocardiography Transesophageal echocardiography - Atrial Fibrillation, Atrial Flutter | Unknown | Medical University of Warsaw | 200 | 2018-10-01 | 2018-11-05 | |
| Renal Function Post Cardioversion for Atrial Fibrillation Electrical atrial fibrillation Cardioversion, Cardioversion - Atrial Fibrillation, Renal Insufficiency | Unknown | Hadassah Medical Organization | 150 | 2018-07-11 | 2019-08-07 | |
| Risk of Stroke and Silent Cerebrovascular Thromboembolism After Cardioversion of Atrial Fibrillation Cardioversion, Oral Anticoagulant - Atrial Fibrillation, Cardioversion | Phase 3 | Completed | Suleyman Demirel University | 112 | 2013-08-01 | 2024-11-15 |
| Optimization of Initial Energy for Cardioversion of Atrial Fibrillation With Biphasic Shocks 100 joule as first biphasic shock energy, 120 joule as first biphasic shock energy - Atrial Fibrillation, Cardioversion | Not applicable | Unknown | Maria Vittoria Hospital | 154 | 2013-05-01 | 2013-07-30 |
Atrial Fibrillation (7) · Atrial Flutter (1) · Renal Insufficiency (1) · Stroke (1) · Thromboembolism (1)
Arrhythmias, Cardiac (7) · Cardiovascular Diseases (7) · Heart Diseases (7) · Pathologic Processes (7) · Pathological Conditions, Signs and Symptoms (7) · Vascular Diseases (2) · Brain Diseases (1) · Central Nervous System Diseases (1) · Cerebrovascular Disorders (1) · Embolism and Thrombosis (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Nervous System Diseases (1)
Electric Countershock (2) · Anticoagulants (1) · Echocardiography, Transesophageal (1)
Habib Khan (1) · Hadassah Medical Organization (1) · Maria Vittoria Hospital (1) · Mayo Clinic (1) · Medical University of Warsaw (1) · Ottawa Heart Institute Research Corporation (1) · Suleyman Demirel University (1) · Yale University (1)
United States (2) · Canada (1) · Israel (1) · Italy (1) · Poland (1) · Turkey (Türkiye) (1)
Allan S Jaffe, MD (1) · Joseph Ross, MD, MHS (1) · Massimo Imazio, MD (1) · Mehmet Ozaydin, Professor,MD (1) · Mehrdad Golian (1) · Peter Noseworthy, MD (1) · Sanket Dhruva, MD, MHS (1) · Sreekanth Vemulapalli, MD (1)